RELATED STUDY
Editorial: Insights on cannabinoid translational science and medicine: the endocannabinoidome as a target for clinical practice
Key Findings: This editorial outlines the new inclusion of the endocannabinoidome as part of the endocannabinoid system and presents possible future therapeutic targets within each.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Brazil, Italy, United States
Year of Pub: 2024
Cannabinoids Studied: Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC), Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH), 2-Arachidonoyl Glycerol (2-AG), Monoacylglycerol Lipase (MAGL), Endocannabinoid (unspecified), Other Related Compounds, Tetrahydrocannabivarin (THCV), Delta-8-THC, Cannabidivarin (CBDV), Microbiome
Phytocannabinoid Source: Not Applicable
Citation: Sampaio L, et al. Editorial: Insights on cannabinoid translational science and medicine: the endocannabinoidome as a target for clinical practice. Front Neurosci. 2024; 18:1432892. doi: 10.3389/fnins.2024.1432892
Authors: Sampaio L, Campos RMP, Karhson D, Iannotti FA
